INBP

Integrated BioPharma Inc

USOTC

Add Alert

INBP

Integrated BioPharma Inc

USOTC

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

greasemonkeyshoes Free

02/13/20 2:46 PM

Post #452

Re: #451: @bobkubecka - INBP 10k filed

Added few more shares.....
this baby is on fire and chieeeeppppppppppppppp!

bobkubecka Grandfathered

02/12/20 6:37 PM

Post #451

INBP 10k filed
https://www.otcmarkets.com/filing/html?id=13912523&guid=lQACUKuJUTjIW3h

Golden Cross Free

11/13/19 4:03 PM

Post #450

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2019
Press Release | 11/13/2019
HILLSIDE, NJ / ACCESSWIRE / November 13, 2019 / Integrated BioPharma, Inc. (OTC BB:INBP) (the "Company") reports it financial results for the quarter ended September 30, 2019.

Revenue for the quarter ended September 30, 2019 was $11.4 million compared to $10.3 million for the quarter ended September 30, 2018, an increase of $1.1 million or 10.7%. The Company had operating income for the quarter ended September 30, 2019 of $0.5 million compared to operating income of $0.4 million for the quarter ended September 30, 2018.

For the quarter ended September 30, 2019, the Company had net income and diluted net income of $0.3 million or $0.01 per share of common stock, compared with net income and diluted net income of $0.2 million or $0.01 per share of common stock for the quarter ended September 30, 2018.

"We are excited to report that our revenue increased by approximately 11% in the quarter ended September 30, 2019 and that our revenue from our two significant customers in our Contract Manufacturing Segment remained consistent; representing approximately 91% and 89% of total revenue in the quarters ended September 30, 2019 and 2018, respectively," said Riva Sheppard, Co-Chief Executive Officer of the Company.

A summary of our financial results for the three months ended September 30, 2019 follows:

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)
(unaudited)
Three Months Ended
September 30,
2019 2018
Total revenue
$ 11,406 $ 10,304
Cost of sales
10,007 9,085
Gross profit
1,399 1,219
Selling and administrative expenses
923 814
Operating income
476 405
Other expense, net (1)
(127 ) (191 )
Income before income taxes
349 214
Income tax expense, net
37 55
Net income
$ 312 $ 159
Net income per common share:
Basic
$ 0.01 $ 0.01
Diluted
$ 0.01 $ 0.01
Weighted average common shares outstanding:
Basic
29,565,943 27,218,786
Diluted
30,724,633 27,963,604
(1) Includes interest expense of $124 and $200, respectively.
SOURCE: Integrated BioPharma, Inc.

View source version on accesswire.com:
https://www.accesswire.com/566451/Integrated-BioPharma-Reports-Results-for-its-Quarter-Ended-September-30-2019

bobkubecka Grandfathered

08/29/19 1:42 PM

Post #449

INBP 10k filed
https://www.otcmarkets.com/filing/html?id=13618471&guid=-U6IUe4whcTGP3h

bonedaddy77 Free

06/03/19 3:22 PM

Post #448

I'm surprised there isn't more love here. I saw Q3 financials and they look pretty good.

greasemonkeyshoes Free

05/15/19 8:45 PM

Post #447

eps=3c.....
or 12c x 5(pe) = 60c stock in the making.wooowwwww.

greasemonkeyshoes Free

02/14/19 11:33 AM

Post #446

Not bad....
Revenue up 11%
eps .008c or 3.2c annualized
inventory is up $2.0 million,must expect $12+ million shipment next few quarters.

greasemonkeyshoes Free

02/08/19 1:43 PM

Post #445

Re: #444: @Knowledge is King - Is this a prediction for the 12/18 Q?

Yes,for q2 which ended on 12/31/18......
ER due out most likely today.This company has many moving parts,I hope $500k operating income stays up,generating enough cash and lower their debt level due in 2020.Once inbp got its act together,top line of $10+ million/q can do a lot of damage(in a positive way).

Knowledge is King PremiumMember

02/08/19 1:17 PM

Post #444

Re: #443: @greasemonkeyshoes - This ER numbers........

Is this a prediction for the 12/18 Q?

greasemonkeyshoes Free

02/08/19 11:47 AM

Post #443

This ER numbers........
rev 11.4 million
cost 10.0 million(88%)
sg&a 0.85 million(7%)
net income 0.28 million(2%) or 1c
forward pe@13c:
13c/1c*4=3.3

greasemonkeyshoes Free

09/12/18 9:21 PM

Post #442

Buy.....
q4(6/30/18):
revenue up 12%
net income $818k w/change of derivative&others $461k(benefit).
or
this dog is getting rid of its flee,1 or 2 more q to go,before complete eradication.Wooowwwww.

greasemonkeyshoes Free

09/12/18 3:47 PM

Post #441

10Q pending.......
This dog with flee is on the move.A good q coming??

greasemonkeyshoes Free

08/31/18 7:26 PM

Post #440

$5.3 million of convertible debt to equity @65c........
With current quote of the stock at 16c,the greatest thing since the sliced of bread just occured,a gift to the shareholders/company.Nothing can be better than this event.Wooowwwwww.
Bottom line to the capital structure:
$4.0 million net debt reduction,at no dilution to its shareholders.
Saving of $318k of interest expense annually.

aetosellinas Free

10/20/14 5:39 AM

Post #439

What a week INBP & IBIO
I smell some HUGE gains here folks

DChow

10/19/14 10:27 AM

Post #438

Shhhhhhhhhhhhhhhhhhh

aetosellinas Free

10/19/14 8:56 AM

Post #437

Re: #434: @TradeSmart.ai - Surprised more people haven't caught on to this

Oh they will :), very interesting week coming. Given how low the float is here, we may see some crazy runs here

balamidas

10/19/14 1:16 AM

Post #436

Re: #434: @TradeSmart.ai - Surprised more people haven't caught on to this

...

©PROPHETABLE Free

10/19/14 12:52 AM

Post #435

***MARK IT***

NEXT EBOLA RUNNER...

IF YOU'RE NOT LOADING, WE ARE...TIC...TOC...TIC...TOC...TIC...TOC...

TradeSmart.ai PremiumMember

10/18/14 9:44 PM

Post #434

Re: #433: @aetosellinas - INBP-our hidden under the radar gem holding about

Surprised more people haven't caught on to this yet ;]

$INBP

aetosellinas Free

10/18/14 11:53 AM

Post #433

INBP-our hidden under the radar gem holding about 1.7 million shares of IBIO woweeee lol. This is going to get very interesting, with less the a million float who knows how high this can reach here. It's IBIO investment alone is about 5.5 million, what's to stop IBIO from surging up much more ahead if it's recent developments.
Things are going to get very interesting, too bad we're so under the radar, I'm sure that'll change :)

aetosellinas Free

10/18/14 10:20 AM

Post #432

Re: #431: @angelo2112 - People starting to put 2&2 together I see... Nice!

Monster is an understatement, market cap is so low and discounted and the float here is only like 1 million
It's crazy to see still at these levels, people haven't the slightest idea

angelo2112 Free

10/17/14 7:05 PM

Post #431

People starting to put 2&2 together I see... Nice!
This will be a monster runner mark it!

tommie0908 Free

10/17/14 3:51 PM

Post #430

Re: #429: @GOLDMAN STACKS - Boom!!!!

Got me a starter position today

GOLDMAN STACKS Free

10/17/14 3:23 PM

Post #429

Re: #405: @Talc Moan - Investment in iBio, Inc. The Company accounts for

Boom!!!!

©PROPHETABLE Free

10/17/14 3:18 PM

Post #428

Me likey!!!

Talc Moan

10/14/14 6:21 AM

Post #427

Re: #426: @MONEYMADE - NOW YA TELL ME!!! HAHAA NICE FIND

I thought you knew for some reason lol!

MONEYMADE

10/14/14 6:16 AM

Post #426

Re: #425: @Talc Moan - INBP valuation is going through the roof. 21

NOW YA TELL ME!!! HAHAA NICE FIND

Talc Moan

10/14/14 6:10 AM

Post #425

INBP valuation is going through the roof. 21 mill OS and 70% owned by insiders. They own 1.2 million shares of IBIO now valued at almost 3 million dollars.

The share price will keep rising with Ibio's advancement.

Sibware

10/13/14 3:20 PM

Post #424

Re: #422: @Talc Moan - LOL... Tell my wife that plzzzzzz

Well.Houston.We have an INdescriBable Problem==>

I AM your wife.

Been following you since a while, without you knowing it...

Ebola Fever??? Huh!!!!

I'm gonna show you what a fever feels like, tonight!!!

Can you hear me???

CDBLEG

10/13/14 11:39 AM

Post #423

Re: #422: @Talc Moan - LOL... Tell my wife that plzzzzzz

Whats your opinion on this chart here? Been following it and trying to see where this is going. Newbie here

Talc Moan

10/13/14 11:28 AM

Post #422

Re: #421: @Sibware - LMAO! At least, he's good at something...

LOL... Tell my wife that plzzzzzz

Sibware

10/13/14 11:27 AM

Post #421

Re: #420: @Talc Moan - Nah just a pumper "LOL"

LMAO! At least, he's good at something...

Talc Moan

10/13/14 11:23 AM

Post #420

Re: #419: @Sibware - You know him too??? They say he's very good...

Nah just a pumper "LOL"

Sibware

10/13/14 11:19 AM

Post #419

Re: #418: @Talc Moan - Lmao!

You know him too??? They say he's very good...

Talc Moan

10/13/14 11:10 AM

Post #418

Re: #417: @Sibware - Heard_they_have_an advisor named smitter or something like that...Lol...

Lmao!

Sibware

10/13/14 11:09 AM

Post #417

Re: #415: @Talc Moan - Yep, and they prob have some insider knowledge

Heard_they_have_an advisor named smitter or something like that...Lol...

Talc Moan

10/13/14 11:09 AM

Post #416

Re: #414: @Sibware - I'm sure they know when's the best time

Make you go hmmmmmmmmmmm

Talc Moan

10/13/14 11:08 AM

Post #415

Re: #414: @Sibware - I'm sure they know when's the best time

Yep, and they prob have some insider knowledge of what is going on over at IBIO.

Sibware

10/13/14 11:07 AM

Post #414

Re: #413: @Talc Moan - They own 1.2 mill IBIO. They better hold

I'm sure they know when's the best time to sell some of their IBIO shares...

What will be interesting also is, what will they do with all that money>>>>

Talc Moan

10/13/14 11:01 AM

Post #413

Re: #412: @Sibware - INBP: Cash coming in... ***

They own 1.2 mill IBIO. They better hold it. IBIO gonna be $10+ prob less than a few weeks. This company is going to be cash heavy!

Sibware

10/13/14 10:44 AM

Post #412

INBP: Cash coming in... ***

Talc Moan

10/13/14 10:42 AM

Post #411

Re: #410: @aetosellinas - .30 next .38-.42

The higher IBIO goes the more Value this gets and exposure.

aetosellinas Free

10/13/14 10:42 AM

Post #410

Re: #409: @Talc Moan - .28+++

.30 next .38-.42

Talc Moan

10/13/14 10:32 AM

Post #409

.28+++

aetosellinas Free

10/13/14 10:31 AM

Post #408

Here we go, watch volume this moves like crazy could see .50 today plus

aetosellinas Free

10/13/14 10:24 AM

Post #407

Pop to 30's-45+++
Be ready

Talc Moan

10/13/14 10:06 AM

Post #406

.22

Talc Moan

10/13/14 9:21 AM

Post #405

Investment in iBio, Inc. The Company accounts for its investment in iBio, Inc. (“iBio”) common stock on the cost basis as it retained approximately 6% of its interest in iBio (1,266,706 common shares) (the “iBio Stock”) at the time of the spin-off of this subsidiary in August 2008. The Company reviews its investment in iBio for impairment and records a loss when there is deemed to be an impairment of the investment. There were impairment charges of $152 and $139 recorded in the fiscal years ended June 30, 2014 and 2013, respectively. The market value of the iBio Stock as of June 30, 2014, was approximately $0.5 million. Pursuant to the Company’s Loan Agreement with PNC Bank, National Association (“PNC”), the Company is required to sell the iBio Stock when the trading price of the iBio Stock is less than $0.88 per share for a period of fifteen (15) consecutive trading days on the applicable exchange and utilize all proceeds from such sale to prepay the outstanding principal of the term loan outstanding under the Loan Agreement at such time. In the fiscal years ended June 30, 2014 and 2013, the trading price of the iBio Stock was less than $0.88 for a period of fifteen (15) consecutive trading days. (See Note 6. Senior Credit Facility, Subordinated Convertible Note Payable, net - CD Financial, LLC and other Long Term Debt). As of September 8, 2014, the Company has not sold any shares of the iBio Stock.

Looks like they are gonna be CASH HEAVY soon LOL!

willlbone

10/07/14 12:45 PM

Post #404

Very small float.

DUKES BOY

03/13/14 10:24 PM

Post #403

Scramracing I'm in Pphm left this thing in 2012

Older

Integrated BioPharma Inc (INBP)

Followers	18	Posters	67
Posts (Today)	0	Posts (Total)	452
Created	09/09/07	Type	Free
Moderators

http://www.healthproductscorp.us/

http://www.ibiopharma.com/index.htm

http://www.inb-biotechnologies.com/

http://www.paxispharma.com/

http://finance.yahoo.com/q/h?s=INBP

Integrated BioPharma (Ticker Symbol: INBP) is a well-established biopharma company serving the varied needs of the nutraceutical industry. Through a number of wholly owned subsidiaries INB develops manufactures and distributes, worldwide over 130 products. The Company has recently upgraded and expanded its manufacturing facilities to further increase production capacity.

A leader for many years in providing nutritional supplement products and services, the Company's recent acquisitions propel it into the rapidly growing field of genetically engineered human therapeutics. These acquired companies already have significant competitive presence in the high growth industry of naturally occurring chemotherapeutic anti-cancer agents. Integrated BioPharma's solid business base, long standing industry reputation and experienced management team ensure rapid and significant growth in the coming years.

Integrated BioPharma Companies

AgroLabs, Inc. manufactures and markets healthful nutritional products under the following brands: Naturally Noni, Naturally Pomegranate, Naturally Aloe, andNaturally Mangosteen. These products are distributed nationwide through major mass market, grocery, drug and vitamin retailers.

http://www.AgroLabs.com

Chem International offers a wide range of Roche Vitamins' food and cosmetic products.


Vitamin C (Ascorbic Acid)	Acidulants	Vitamin D3- Liquid Forms
Vitamin E- Liquid Forms	Lutein	Vitamin D3- Dry Forms
Vitamin E- Dry Forms	Lycopene	Vitamin H (Biotin)
Vitamin E- Natural Source	Zeaxanthin	Vitamin K1 (Phytonadione)
Vitamin A- Liquid Forms	Ropufa	Folic Acid (Vitamin B Conjugate)
Vitamin A- Dry Forms	Vitamin A- Liquid Forms	Standard Blended Premixes
Vitamin B1 (Thiamine)	Vitamin E- Liquid Forms
Vitamin B2 (Riboflavin)	Pro Vitamin B5 Panthenol
Vitamin B3 (Niacin/Niacinimide)	Omega 6 Oils Naturals
Vitamin B5 (Pantothenic Acid)	Sunscreens
Vitamin B6 (Pyridoxine)	Emulsifiers
Vitamin B12 (Cyanocobalamin)	Carotenoids

http://www.chemintl.com/

IHT Health Products, Inc. sells and distributes fine chemicals, including science-based proprietary products and value added formulations to the nutritional, pharmaceutical, food, and cosmetic industries. IHT products include vitamins, amino acids, herbal extracts, OTC pharmaceuticals, excipients, and innovative patented products.


Acerola Extract	Chitosan	Gingko Biloba Extract	L-Carnitine Base
Alpha Lipoic Acid	Chlorella Powder		L-Glutamine
Ascorbic Acid 97%	Choline Bitartate	Green Tea Extract	Mahuang Extract
Bee Pollen Powder	Chondoroitin Sulfate	Guarana Extract	Nettle Root Powder
Bladderwrack Powder	Citrus Aurantium	Grape Skin Extract	Olive Leaf Extract
Bilberry Extract	Colostrum	Horny Goat Weed	Pau D'Arco Powder
Biotin Powder	Cranberry Extract	Horsetail Herb Powder	Riboflavin Powder
Black Cohosh Powder	Dandelion Powder	Inositol	White Willow Bark 15%
Burdock Root Powder	Dong Quai
Caffeine Anhydrous	Echinacea Purpurea
Cascara Sagrada	Fo Ti Root Powder
Cat's Claw 4:1 Extract	Folic Acid
Catuaba	Gacinia Cambogia
Chitin Powder	Ginger Root Powder

http://healthproductscorp.us/iht/

Established in 1922, Manhattan Drug Company provides vitamins and nutritional formulations to customer specifications.

	Manufacturing of tablets, capsules, or blends
	Analytical and Microbioloical testing by our in-house laboratories
	Packaging and Labeling in bulk
	Assistance in product registration abroad
	Distribution of finished product

The Vitamin Factory sells nutritional supplements directly to the consumer through mail order catalogs and over the Internet.


Specialty Formulas	E 200 iu Natural Blend	Shark Cartilage 500mg	Mega Multiple #75
Vitamin A 10,000 iu	E 400 iu Natural Blend	Pycnogenol 25mg	Bilberry Extract 60mg
Vitamin A 25,000 iu	E 1000 iu Natural Blend	Creatine 300 grams	Cat's Claw 500mg
Beta Carotene 6mg	Calcium 900	MAP	Cayenne 500mg
B Complex 50	Calcium Citrate	MSM 1000mg	Black Cohosh
B Complex 100	Magnesium 100mg	L-Carnitine 250mg	Dong Quai
Folic Acid	Chitosan 500mg	BCAA	Ginger 550mg
Ginseng	Saw Palmetto	PhytoSel 100 mcg	PhytoChrome 100 mcg
Lecithin 1200mg	Soy Isoflanoves	PhytoSel 200 mcg	PhytoChrome 200 mcg
Papaya	Lycopene 10mg	Calcium 900/450	Gingko Bilboa 60mg
Vitamin B1	Evening Primrose	Bromelain 500mg	MultiMins
Vitamin B6	Grapeseed Extract
Vitamin B12	CoEnzyme Q-10 30mg
Ester C 500mg	IP-6
Ester C 1000mg	Lutein
Vitamin C 500	Omega 3 Fish Oil
Vitamin C 1000	Melatonin 300mcg

http://www.vitafac.com/

Management Team

Gerald Kay

Chairman of the Board, CEO, and Shareholder. E. Gerald Kay has served as Chairman of the Board and President of the Company and its predecessor since 1980. He was president until May 1999.

Dina L. Masi

Chief Financial Officer and Senior Vice President. Ms. Masi most recently operated a financial services consulting firm providing accounting and financial services to small business owners. She also served as a consultant to SEC registrants. Prior to that, she served as the Chief Financial Officer of a mortgage finance company and a Senior Vice President and Management Information Officer of a financial consulting services company. Before that, she served as the Chief Financial Officer of The Aegis Consumer Funding Group, Inc., a publicly traded consumer finance company specializing in automobile receivables. Ms. Masi began her career as an auditor with BDO Seidman, LLP.

Riva Sheppard

Vice President, Sales and Manufacturing. Riva Kay Sheppard has served as Vice President and Director of the Company since May 1991. Prior to joining the Company in 1991, she was with United Jersey Bank.

Christina Kay

Vice President, Logistics. Christina Kay served as Vice President and Director of the Company since December 1994. Previously she was with the New York law firm of Squadron, Ellenoff, Plesant, Sheinfeld & Sorkin.